SCHEMBL796954

SCHEMBL796954

COc1cc(-c2nc(-c3nc(N)nc(Nc4ccccc4)n3)no2)ccn1.Nc1nc(Nc2cccc(F)c2)nc(-c2noc(-c3ncccc3F)n2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.39
GRM5 P41594 2/20 0.37
ALOX5AP P20292 1/20 0.36
MAPT P10636 4/20 0.36
TP53 P04637 4/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
TDO2 P48775 1/20 0.36
RAD52 P43351 1/20 0.35
ABCG2 Q9UNQ0 2/20 0.35
IMPDH2 P12268 1/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL797445 0.86 TP53 (0.40) GRM5MAPTTP53POLBMEN1
SCHEMBL15477231 0.86 S1PR1 (0.50) S1PR1GRM5ALOX5APMAPTTP53
SCHEMBL796497 0.82 NPC1 (0.42) MAPTMEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL796477 0.74 TP53 (0.49) S1PR1MAPTTP53POLBMEN1
SCHEMBL796837 0.71 CDK9 (0.46) GRM5MAPTTP53MEN1KMT2A
SCHEMBL795790 0.71 AURKA (0.41) S1PR1MAPTMEN1KMT2AKDM4E
SCHEMBL795637 0.70 MAPT (0.43) MAPTTP53POLBMEN1KMT2A
SCHEMBL796445 0.68 S1PR1 (0.48) S1PR1GRM5ALOX5APMAPTTP53
SCHEMBL807929 0.68 ACHE (0.40) S1PR1
SCHEMBL795351 0.68 BRAF (0.40) GRM5MAPTTP53POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616465-A1 TRIAZINE-OXADIAZOLES Novartis AG (CH) 2013-07-24 EP disclosed
WO-2012035023-A1 TRIAZINE-OXADIAZOLES NOVARTIS AG (CH) 2012-03-22 WO disclosed